as of 08-31-2026 9:43am EST
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 5.7M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 5.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.10 | EPS Growth: | 23.94 |
| 52 Week Low/High: | $0.04 - $0.07 | Next Earning Date: | N/A |
| Revenue: | $502,729,000 | Revenue Growth: | 27.79% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -0.66 | Index: | N/A |
| Free Cash Flow: | -27787000.0 | FCF Growth: | N/A |
See how STLNW stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "STLNW Starling Oncology Inc. Warrant - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.